ketotifen has been researched along with Cirrhosis in 4 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Excerpt | Relevance | Reference |
---|---|---|
" Oral treatment with ketotifen, an inhibitor of mast cell degranulation, at a dose comparable to that recommended for man, was associated with a decrease in both mast cell degranulation and in skin fibrosis, suggesting the potential for its use in human scleroderma." | 7.68 | Ketotifen prevents skin fibrosis in the tight skin mouse. ( Harley, R; LeRoy, EC; Walker, M, 1990) |
"Treatment with ketotifen decreased tissue hydroxyproline levels, histological damage, and the stenosis index." | 5.32 | Ketotifen ameliorates development of fibrosis in alkali burns of the esophagus. ( Karaoglu, AO; Ozutemiz, O; Tuncyurek, M; Yenisey, C; Yukselen, V, 2004) |
" Oral treatment with ketotifen, an inhibitor of mast cell degranulation, at a dose comparable to that recommended for man, was associated with a decrease in both mast cell degranulation and in skin fibrosis, suggesting the potential for its use in human scleroderma." | 3.68 | Ketotifen prevents skin fibrosis in the tight skin mouse. ( Harley, R; LeRoy, EC; Walker, M, 1990) |
"Treatment with ketotifen decreased tissue hydroxyproline levels, histological damage, and the stenosis index." | 1.32 | Ketotifen ameliorates development of fibrosis in alkali burns of the esophagus. ( Karaoglu, AO; Ozutemiz, O; Tuncyurek, M; Yenisey, C; Yukselen, V, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Willems, M | 1 |
Seβenhausen, P | 1 |
Gies, I | 1 |
Vloeberghs, V | 1 |
Tournaye, H | 1 |
Van Saen, D | 1 |
Goossens, E | 1 |
Monument, MJ | 1 |
Hart, DA | 1 |
Befus, AD | 1 |
Salo, PT | 1 |
Zhang, M | 1 |
Hildebrand, KA | 1 |
Yukselen, V | 1 |
Karaoglu, AO | 1 |
Ozutemiz, O | 1 |
Yenisey, C | 1 |
Tuncyurek, M | 1 |
Walker, M | 1 |
Harley, R | 1 |
LeRoy, EC | 1 |
4 other studies available for ketotifen and Cirrhosis
Article | Year |
---|---|
Intratesticular xenografting of Klinefelter pre-pubertal testis tissue as potential model to study testicular fibrosis.
Topics: Animals; Female; Fibrosis; Humans; Ketotifen; Klinefelter Syndrome; Longitudinal Studies; Male; Mice | 2022 |
The mast cell stabilizer ketotifen reduces joint capsule fibrosis in a rabbit model of post-traumatic joint contractures.
Topics: Actins; Animals; Anti-Allergic Agents; Collagen Type I; Collagen Type III; Contracture; Fibrosis; Hi | 2012 |
Ketotifen ameliorates development of fibrosis in alkali burns of the esophagus.
Topics: Animals; Burns, Chemical; Esophageal Stenosis; Esophagus; Fibrosis; Histamine H1 Antagonists; Ketoti | 2004 |
Ketotifen prevents skin fibrosis in the tight skin mouse.
Topics: Animals; Disease Models, Animal; Fibrosis; Ketotifen; Mast Cells; Mice; Mice, Inbred C57BL; Sclerode | 1990 |